Inhibition of the chimeric DnaJ‐PKAc enzyme by endogenous inhibitor proteins-Reference-Cited by-同舟云学术

Inhibition of the chimeric DnaJ‐PKAc enzyme by endogenous inhibitor proteins

Published:2019-04-02 Issue:8 Volume:120 Page:13783-13791
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Averill April M.¹,Rehman Hibba tul²³,Charles Joseph W.⁴,Dinh Timothy A.⁵⁶,Danyal Karamatullah⁷,Verschraegen Claire F.⁸,Stein Gary S.³⁹,Dostmann Wolfgang R.⁴,Ramsey Jon E.³⁹^ORCID

Affiliation:

1. Department of Microbiology and Molecular Genetics, Larner College of Medicine University of Vermont Burlington Vermont

2. Division of Hematology and Oncology Department of Medicine, Larner College of Medicine University of Vermont Burlington Vermont

3. University of Vermont Cancer Center Burlington Vermont

4. Department of Pharmacology, Larner College of Medicine University of Vermont Burlington Vermont

5. Department of Biomedical Sciences, College of Veterinary Medicine Cornell University Ithaca New York

6. Curriculum in Genetics and Molecular Biology University of North Carolina at Chapel Hill Chapel Hill North Carolina

7. Department of Pathology, Larner College of Medicine University of Vermont Burlington Vermont

8. Division of Medical Oncology The Ohio State Comprehensive Cancer Center Columbus Ohio

9. Department of Biochemistry,, Larner College of Medicine University of Vermont Burlington Vermont

Funder

Fibrolamellar Cancer Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28651

Reference27 articles.

1. Fibrolamellar hepatocellular carcinoma in the USA, 2000–2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database

2. Fibrolamellar Carcinoma: A Review with Focus on Genetics and Comparison to Other Malignant Primary Liver Tumors

3. DNAJB1-PRKACA is specific for fibrolamellar carcinoma

4. Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma

5. Structural insights into mis-regulation of protein kinase A in human tumors

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC;ACS Chemical Biology;2024-08-13

2. Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma;Cell Reports Medicine;2024-08

3. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma;PLOS Genetics;2024-03-21

4. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma;2023-06-04

5. Biochemical Discovery, Intracellular Evaluation, and Crystallographic Characterization of Synthetic and Natural Product Adenosine 3′,5′-Cyclic Monophosphate-Dependent Protein Kinase A (PKA) Inhibitors;ACS Pharmacology & Translational Science;2023-03-21